Inventor · disambiguated record
Ian Edward David Smith
Also filed as: SMITH IAN E D · SMITH IAN EDWARD DAVID
8 granted patents·11 pending applications·186 citations·filing 1999–2024
88Inventor score
Top patents by PatentIndex Score
19 records- 0197US10336744B21AP E3 ligase directed proteolysis targeting chimeric moleculesGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 2, 2019·50 cites·2 claims
- 0291US10730862B2Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligaseUNIV YALE·Filed 2013·Granted Aug 4, 2020·15 cites·14 claims
- 0389US9988376B2Benzothiophene derivatives as estrogen receptor inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 5, 2018·9 cites·21 claims
- 0487US6451804B1Heteroalkylamino-substituted bicyclic nitrogen heterocyclesSYNTEX LLC·Filed 2000·Granted Sep 17, 2002·35 cites·31 claims
- 0583US6150373ABicyclic nitrogen heterocyclesHOFFMANN LA ROCHE·Filed 1999·Granted Nov 21, 2000·66 cites·16 claims
- 0675US10781205B2Conjugates comprising RIPK2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Sep 22, 2020·1 cites·9 claims
- 0774US2024317729A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2024·Application pending·0 cites
- 0873US6642241B1Alkylamino-substituted bicyclic nitrogen heterocyclesSYNTEX LLC·Filed 2000·Granted Nov 4, 2003·9 cites·22 claims
- 0972US10435391B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Oct 8, 2019·1 cites·6 claims
- 1059US2019382381A1Novel compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1154US2019127359A1Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseUNIV YALE·Filed 2018·Application pending·0 cites
- 1252US2019263798A1Novel compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1344US2007191378A1Anthranilic acid derivatives and their use as activators of the hm74a receptorSMITHKLINE BEECHAM CORP·Filed 2004·Application pending·0 cites
- 1443US2008221108A1Anthranilic Acid Derivatives As Hm74A Receptor AgonistsHATLEY RICHARD·Filed 2006·Application pending·0 cites
- 1541US2010099690A1Xanthine derivatives as selective hm74a agonistsHEER JAG PAUL·Filed 2006·Application pending·0 cites
- 1640US2008139565A1Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular DyslipidaemiaCAMPBELL MATTHEW·Filed 2006·Application pending·0 cites
- 1737US2008242666A11-6-Substituted (3R,6R)-3-(2,3-Dihydro-1H-Inden-2-Yl)-2,5-Piperazinedione Derivatives as Oxytocin Receptor Antagonists For the Treatment of Preterm Labour, Dysmenorrhea and EndometriosisLEACH COLIN ANDREW·Filed 2005·Application pending·0 cites
- 1836US2021238162A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 1928US2012058984A1Pyrimidine derivatives used as itk inhibitorsALDER CATHERINE MARY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ian Edward David Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →